We also acknowledge funding from the Children‘s Tumor Foundation Synodos Low-Grade Glioma Initiative that aims to comprehensively characterize the genetic and genomic changes in NF1-LGG as a means to develop more accurate preclinical models of these common tumors. The gene discussed is NF1; the disease is central nervous system cancer.